Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer's -December 19, 2023 at 09:21 am EST
IGC Pharma, Inc. , a clinical-stage pharmaceutical company, announced today that Divisional Direction of Patents, Mexico, has issued a Granting Office Action for its treatment of Alzheimer’s...
Source: marketscreener.com